Bhavana Pothuri

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Endometrial Cancer

Clinical Practice

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, Ignace Vergote, Bradley J Monk, Annika Auranen, Larry J Copeland, Roberto Sabbatini, Thomas J Herzog, Philippe Follana, Bhavana Pothuri, Elena Ioana Braicu, Colleen McCormick, Alfonso Yubero, Richard G Moore, Peter Vuylsteke, Nicoline Raaschou-Jensen, Whitney York, John Hartman, Antonio Gonzáles Martin
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (7) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, Ignace Vergote, Bradley J Monk, Annika Auranen, Larry J Copeland, Roberto Sabbatini, Thomas J Herzog, Philippe Follana, Bhavana Pothuri, Elena Ioana Braicu, Colleen McCormick, Alfonso Yubero, Richard G Moore, Peter Vuylsteke, Nicoline Raaschou-Jensen, Whitney York, John Hartman, Antonio Gonzáles Martin
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (7) (2024)
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, Ignace Vergote, Bradley J Monk, Annika Auranen, Larry J Copeland, Roberto Sabbatini, Thomas J Herzog, Philippe Follana, Bhavana Pothuri, Elena Ioana Braicu, Colleen McCormick, Alfonso Yubero, Richard G Moore, Peter Vuylsteke, Nicoline Raaschou-Jensen, Whitney York, John Hartman, Antonio Gonzáles Martin
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (7) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, Ignace Vergote, Bradley J Monk, Annika Auranen, Larry J Copeland, Roberto Sabbatini, Thomas J Herzog, Philippe Follana, Bhavana Pothuri, Elena Ioana Braicu, Colleen McCormick, Alfonso Yubero, Richard G Moore, Peter Vuylsteke, Nicoline Raaschou-Jensen, Whitney York, John Hartman, Antonio Gonzáles Martin
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (7) (2024)
Bhavana Pothuri, Premal Thaker, Adrienne Moore, Rosa Espinosa, Kara Medina, Deborah Collyar, Kathleen Lutz, Mihaela C Munteanu, Brian M Slomovitz
Improving diverse patient enrollment in clinical trials, focusing on Hispanic and Asian populations: recommendations from an interdisciplinary expert panel. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Thomas J Herzog, Shaun A Wahab, Mansoor Raza Mirza, Bhavana Pothuri, Ignace Vergote, Whitney S Graybill, Izabela A Malinowska, Whitney York, Jean A Hurteau, Divya Gupta, Antonio Gonzáles Martin, Bradley J Monk
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (11) (2023)
Hannah Karpel, Elizabeth Manderski, Bhavana Pothuri
Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, Jubilee Brown, Sharad A Ghamande, Cara A Mathews, David M O'Malley, Rebecca S Kristeleit, Valentina Boni, Adriano Gravina, Susana Banerjee, Rowan E Miller, Joanna Pikiel, Mansoor Raza Mirza, Ninad Dewal, Grace Antony, Yuping Dong, Eleftherios Zografos, Jennifer T Veneris, Sarah A Cook
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Erika Paige Hamilton, Giorgio Valabrega, Toon Van Gorp, Jalid Sehouli, David Cibula, Tally Levy, Stephen Welch, Debra L Richardson, Eva M Guerra, Giovanni Scambia, Stéphanie Henry, Pauline Wimberger, David Scott Miller, Jaroslav Klat, Jerónimo Martínez-Garcia, Francesco Raspagliesi, Bhavana Pothuri, Ignacio Romero, Alice Bergamini, Brian Slomovitz, Fabienne Schochter, Estrid Høgdall, Lorena Fariñas-Madrid, Bradley J Monk, Dayana Michel, Michael G Kauffman, Sharon Shacham, Mansoor Raza Mirza, Vicky Makker, null null
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Bhavana Pothuri, Allison L Brodsky, Joseph A Sparano, Stephanie V Blank, Mimi Kim, Dawn L Hershman, Amy Tiersten, Brian F Kiesel, Jan H Beumer, Leonard Liebes, Franco Muggia
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up. Cancer chemotherapy and pharmacology 85 (4) (2020)
Melissa K Frey, Bhavana Pothuri
Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecologic oncology research and practice 4 (2017)